DINESH V. PH D. PATEL - 28 Feb 2022 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role: President and CEO, Director
Signature: /s/ Donald A. Kalkofen, Attorney-in-Fact for Dinesh V. Patel, Ph.D.
Issuer symbol: PTGX
Transactions as of: 28 Feb 2022
Net transactions value: -$112,853
Form type: 4
Filing time: 02 Mar 2022, 19:39:43 UTC
Previous filing: 17 Feb 2022
Next filing: 14 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTGX	Common Stock	Tax liability	$112,853	-4,648	-0.91%	$24.28	503,760	28 Feb 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 13,438 vested restricted stock units on February 28, 2022.